HLLY News and Press, Holley Inc. From 11/15/23

2023-11-15 08:45:04 ET SciSparc ( SPRC ) +86% Positive Results Show its Treatment has a Remarkable Impact on Alzheimer's Agitation. Kinnate Biopharma  ( KNTE ) +41% . Solid Biosciences  ( SLDB ) +27% gets FDA okay for clinical testing of DMD gene th...

2023-11-15 03:28:57 ET Summary Holley’s net sales rose by 1.1% in Q3 2023 while the adjusted EBITDA margin soared to 19% thanks to cost savings. Also, free cash flow came in at $21.7 million and Holley slashed its net debt by $20.9 million during the quarter. In my view...

2023-11-14 10:58:56 ET More on Consumer Discretionary Select Sector SPDR ETF Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? XLY: Consumer Discretionary Dashboard For October Macro Headwinds Ahead, Expect Volatility In ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Holley To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Holley between July 21, 2021 and February 6, 2023 and would like to discuss your legal rights, call F...

2023-11-11 17:17:02 ET Holley Inc. (HLLY) Q3 2023 Results Conference Call November 08, 2023 08:30 AM ET Company Participants Ross Collins - IR Matt Stevenson - President and CEO Jesse Weaver - CFO Conference Call Participants Brian McNamara - Canaccor...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Holley To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Holley between July 21, 2021 and February 6, 2023 and would like to discuss your legal rights, call F...

2023-11-08 07:37:34 ET More on Holley Holley: Weak Company With Only Problems Ahead Evaluating Holley Inc. Investment Potential Amidst Elevated Risk And Interest Rates Holley Shifts Into A Higher Gear (Rating Upgrade) Holley announces $25 million debt pay dow...

Strong performance yields year-over-year revenue growth while delivering meaningfully improved margins through operational improvements Solid cash flow generation and debt paydown significantly reduces net leverage Comprehensive business transformation underway to unlock g...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Holley Inc. (HLLY) is expected to report $0.02 for Q3 2023